Surgery for pancreatic neuroendocrine tumors during the COVID-19 pandemic: a retrospective cohort from a high-volume center - Poll - MDSpire

Surgery for pancreatic neuroendocrine tumors during the COVID-19 pandemic: a retrospective cohort from a high-volume center

  • By

  • Salvatore Paiella

  • Luca Landoni

  • Matteo De Pastena

  • Giovanni Elio

  • Fabio Casciani

  • Sara Cingarlini

  • Mirko D’Onofrio

  • Giulia Maistri

  • Ivan Ciatti

  • Massimiliano Tuveri

  • Maria Vittoria Davì

  • Claudio Luchini

  • Katia Donadello

  • Gessica Manzini

  • Giuseppe Malleo

  • Roberto Salvia

  • July 21, 2024

  • 0 min

Share

Original Source(s)

Surgery for pancreatic neuroendocrine tumors during the COVID-19 pandemic: a retrospective cohort from a high-volume center

  • by Salvatore Paiella, Luca Landoni, Matteo De Pastena, Giovanni Elio, Fabio Casciani, Sara Cingarlini, Mirko D’Onofrio, Giulia Maistri, Ivan Ciatti, Massimiliano Tuveri, Maria Vittoria Davì, Claudio Luchini, Katia Donadello, Gessica Manzini, Giuseppe Malleo, Roberto Salvia

  • July 21, 2024

Related Content

IFSO Worldwide Survey 2020–2021: Current Trends for Bariatric and Metabolic Procedures

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

30-Day Morbidity and Mortality of Bariatric Surgery During the COVID-19 Pandemic: a Multinational Cohort Study of 7704 Patients from 42 Countries